Safety profile of lutetium-177 in patients with impaired renal function: A retrospective analysis of adverse events in mCRPC treatment. Dr. Saylani highlighted that Lutetium-177 vipivotide tetraxetan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback